Related by context. All words. (Click for frequent words.) 71 microbiological eradication 67 clinically evaluable 66 microbiologically evaluable 66 p = NS 65 BARACLUDE ® 65 oxycodone CR 65 deep venous thromboses 65 % CI #.#-#.# [003] 65 complete cytogenetic response 65 FluCAM arm 65 invasive aspergillosis 64 imipenem 64 % Confidence Interval 64 undetectable viral 64 ertapenem 64 HBeAg negative patients 64 tipranavir ritonavir 64 sustained virologic response 64 ALT elevation 64 ACTEMRA TM 63 external genital lesions 63 doripenem 63 recurrent venous thromboembolism 63 CIN3 63 PASI scores 63 experienced virologic failure 63 achieved ACR# 63 lopinavir r arm 63 HBeAg seroconversion 63 tolterodine ER 63 TAXUS p value 63 hypophosphatemia 63 plus aztreonam 63 hepatitis C genotype 63 XIENCE V PROMUS Stent 63 placebo dexamethasone 63 CIN3 + 63 CR nPR 63 comparator arm 63 cEVR 63 advanced adenomas 63 TLUS 63 TEAEs 63 Stomatitis 62 5-FU/LV 62 underwent resection 62 interferon ribavirin 62 ARCALYST ® 62 leukopenia 62 sustained virological response 62 achieved CCyR 62 genital herpes infections 62 achieved sustained virological 62 adjunctive placebo 62 Prostatic 62 MCyR 62 fatigue asthenia 62 % CI #.#-#.# [007] 62 CP CPPS 62 serum urate levels 62 nondiabetic patients 62 pCR 62 locoregional recurrence 62 amoxicillin clavulanate 62 achieving PASI 62 arterial thromboembolic events 62 TMP SMX 62 CIN2 + 62 % CI #.#-#.# [008] 62 NMIBC 62 severe exacerbations 62 median survivals 62 Folfox 62 chlamydial infection 62 VaD 62 recurrent genital herpes 62 HBeAg 62 postoperative infection 62 reinfarction 62 DAS# CRP 62 CI #.#-#.# [002] 61 DAS# remission 61 mcg QD 61 VFEND 61 Partial Response 61 tipranavir r 61 bacteraemia 61 biochemical relapse 61 Papillary 61 confidence interval #.#-#.# 61 LV dysfunction 61 oral allopurinol 61 anastomotic leak 61 chronic HBV 61 suboptimal adherence 61 Basal Cell 61 receiving VICTRELIS 61 nadroparin 61 nonmetastatic 61 neutropaenia 61 pT2 61 Kaplan Meier estimates 61 FOLFOX4 61 pegylated interferon alfa 61 relapsed MM 61 invasive candidiasis 61 genotype 1b 61 Hypotension 61 Improves Outcomes 61 endometrial hyperplasia 61 Non inferiority 61 titrated glipizide 61 Patients Receiving 61 candidemia 61 virologic failures 61 Hormone Refractory Prostate Cancer 61 APTIVUS R 61 morphometric vertebral fractures 61 Ishak fibrosis score 61 salmeterol fluticasone 61 Viread Emtriva 61 Virologic 61 Chronic Prostatitis 61 clodronate 61 Neoplasms 60 HPV-#/# 60 advanced adenoma 60 Urinary Tract Infections 60 venous blood clots 60 hypovitaminosis D 60 PSA nadir 60 Renal Cell Carcinoma 60 Stent thrombosis 60 symptomatic intracranial hemorrhage 60 oral Hycamtin 60 Community Acquired Pneumonia 60 fructose intolerance 60 orchitis 60 hyperlipemia 60 CIMZIA TM certolizumab pegol 60 Biaxin R 60 seropositivity 60 Operative mortality 60 imiquimod cream 60 Septic Shock 60 venous thromboembolic disease 60 complete cytogenetic 60 Helicobacter pylori infection 60 acute rheumatic fever 60 salmeterol fluticasone propionate 60 Chronic Sinusitis 60 hepatorenal syndrome 60 Bloodstream Infections 60 low dose Iluvien 60 ibandronate 60 KRAS mutations occur 60 malignant neoplasm 60 Adjuvant Chemotherapy 60 FOLFOX6 60 FOLFIRI alone 60 ximelagatran 60 abacavir Ziagen 60 fosamprenavir 60 dysmenorrhoea 60 p ≤ 60 rebleeding 60 pT3 60 highly emetogenic 60 oesophageal adenocarcinoma 60 pegIFN 60 Colorectal Cancers 60 Crohn Disease Activity 60 neoplasias 60 caspofungin 59 #mg BID [001] 59 cabazitaxel 59 Neutropenia 59 S. aureus isolates 59 HBeAg negative 59 ASCUS 59 receiving ISENTRESS 59 leucopenia 59 -#.# log# 59 Flu Cy 59 Thromboembolism 59 piperacillin tazobactam 59 onset atrial fibrillation 59 mcg albinterferon alfa 2b 59 Pediatric Patients 59 cough dyspnea 59 Helicobacter Pylori 59 dalteparin 59 Hb A1c 59 dysuria 59 recurrent VTE 59 grade cervical intraepithelial 59 gonococcal infection 59 Newly Diagnosed Multiple Myeloma 59 thrombocytopenic 59 HIV HCV coinfected 59 rimonabant #mg 59 Adenomas 59 lichen planus 59 mcg kg REBETOL 59 Adjuvant chemotherapy 59 PREZISTA r arm 59 cinacalcet 59 mIU ml 59 ALT flares 59 lymphocyte count 59 CCyR 59 metastatic malignant 59 prednisone prednisolone 59 HSCT 59 nonmelanoma skin cancers 59 Velcade bortezomib 59 rizatriptan 59 colorectal adenoma 59 ipsilateral stroke 59 perioperative mortality 59 elevated LDH 59 low expressors 59 febrile neutropenia 59 posttreatment 59 elevated transaminases 59 chemoradiation therapy 59 specific antigen PSA 59 elevated ALT 59 micafungin 59 Investigational Treatment 59 Posaconazole 59 Relapsing Remitting Multiple Sclerosis 59 Bacterial Vaginosis 59 octreotide LAR 59 Hycamtin ® 59 receiving golimumab 59 log# reduction 59 chlorambucil 59 plus dexamethasone 59 BUPHENYL R sodium phenylbutyrate 59 Malignant Melanoma 59 lymphocytosis 59 Oropharyngeal Candidiasis 59 histologic subtype 59 headache abdominal pain 59 Doxil ® 59 overactive bladder syndrome 59 CIMZIA ™ 59 nonalcoholic steatohepatitis NASH 59 haematologic 59 SVR# 59 renal cell carcinomas 59 hip BMD 59 undetectable HBV DNA 59 trimethoprim sulfamethoxazole 59 receiving XGEVA 59 cytogenetic responses 59 neutropenic 59 underwent surgical resection 59 nausea somnolence 59 Chlamydia infections 59 incidence ≥ 59 lymphopenia 59 HbA 1c levels 59 primary patency 59 pentoxifylline 59 abnormal ejaculation 59 HbA1C 59 Pred Forte 59 undergone radical prostatectomy 58 sotalol 58 invasive fungal infection 58 adverse reactions incidence 58 tapentadol ER 58 atypical ductal hyperplasia 58 antibody titer 58 perioperatively 58 segment binary restenosis 58 lumbar spine BMD 58 leiomyomas 58 myelodysplastic myeloproliferative diseases 58 OAB symptoms 58 recurrent glioblastoma multiforme 58 Toxicities 58 Severe Asthma 58 Thrombotic 58 nonvertebral fracture 58 Beta Blockers 58 HBsAg 58 seminoma 58 Decitabine 58 generalized edema 58 S aureus 58 conjunctival hyperemia 58 #.#ng/ml 58 Non Alcoholic Steatohepatitis 58 recurrent metastatic 58 Genital Warts 58 HeFH 58 Thromboembolic 58 p = ns 58 prolonged QT interval 58 Prostatitis 58 GERD symptom 58 seropositive patients 58 oral vancomycin 58 moderately emetogenic 58 peripheral sensory neuropathy 58 Hepatotoxicity 58 endophthalmitis 58 4mg/kg 58 erosive gastritis 58 smoldering myeloma 58 Moxifloxacin 58 subclinical hyperthyroidism 58 idraparinux 58 Severity Index PASI 58 postintervention 58 TPV r 58 perioperative complications 58 salivary flow 58 Asymptomatic 58 Peginterferon 58 genital ulcer disease 58 H Pylori 58 flutamide 58 Cytogenetic 58 Linezolid 58 Chronic Renal Failure 58 glomerular filtration 58 Noxafil 58 Chlamydia infection 58 cervical intraepithelial neoplasia 58 Reduces Mortality 58 ECOG PS 58 C. difficile infections 58 H pylori 58 Adefovir 58 chlamydial infections 58 Retreatment 58 proctitis 58 tacrolimus ointment 58 β blockers 58 Parnate 58 Cilostazol 58 isoproterenol 58 chronic HCV genotype 58 heFH 58 abnormal cytology 58 mL/min/#.# m 2 58 chronic prostatitis 58 neutrophil counts 58 revascularizations 58 Interferon beta 1b 58 angiographic restenosis 58 seroconverted 58 nosocomial infection 58 CMV infection 58 Malignant Glioma 58 nicardipine 58 doxazosin 58 Acute Myeloid Leukaemia AML 58 mg/m2 dose 58 transaminase elevations 58 glycated hemoglobin levels 58 QTcF 58 WNV encephalitis 58 expressors 58 virologic response 58 Squamous Cell Carcinoma 58 Metastatic Prostate Cancer 58 ritonavir boosted 58 malignant ascites 58 glycosylated hemoglobin HbA1c 58 FluCAM 58 gastrointestinal reflux 58 Thrombocytopenia 58 REYATAZ r arm 58 ACR# response 57 gastrointestinal stromal tumors GIST 57 polyp recurrence 57 Engerix B 57 Clostridium difficile infections 57 binary restenosis 57 seroprotection 57 ductal cancer 57 ULORIC 57 Thal Dex 57 venous thromboembolic events 57 ACE Inhibitors 57 hypercholesterolaemia 57 idiopathic PAH 57 Lung Cancer Survival 57 ATACAND 57 intravesical therapy 57 hepatic cirrhosis 57 paroxysmal AF 57 Nilotinib 57 Endometrial Cancer 57 paresthesias 57 artery reclogging 57 Platelet counts 57 osteosarcomas 57 thrombocytopenia neutropenia 57 Stress Incontinence 57 Fracture Risk 57 receiving PEGINTRON 57 Chronic Constipation 57 T1c 57 -#.# log# copies mL 57 Allergic Rhinitis 57 fluticasone salmeterol 57 amenorrhoea 57 Catheter Associated 57 chills fever headache 57 salmeterol HFA MDI 57 liver histology 57 MACCE 57 stent binary restenosis 57 ‰ ¥ 57 pegylated liposomal doxorubicin 57 Median PFS 57 steroid dexamethasone 57 nonsignificant difference 57 Genital Herpes 57 anagrelide 57 hemodialysis patients 57 PREZISTA ritonavir 57 Ischemic 57 Bacillus Calmette Guerin BCG 57 haematuria 57 Endocarditis 57 Atopic Dermatitis 57 postoperative complication 57 severe neutropenia 57 certolizumab 57 gastrointestinal perforation 57 hormone receptor negative 57 Knee Osteoarthritis 57 carotid stenosis 57 SCIg 57 Ophthalmic Solution 57 CC genotype 57 sirolimus stent 57 REMICADE monotherapy 57 shingles herpes zoster 57 ankylosing spondylitis AS 57 NYHA functional class 57 #q# deletion syndrome 57 receiving prophylactic anticoagulation 57 adriamycin 57 APTIVUS r 57 neutropenic patients 57 ritonavir boosted lopinavir 57 empyema 57 peritoneal cancer 57 acute respiratory tract infections 57 Leukemias 57 epithelial tumors 57 diabetes mellitus DM 57 leukocyte count 57 recurrent DVT 57 hypokalemia 57 Aptivus ® 57 differentiated thyroid 57 Lymphocytic 57 anterior uveitis 57 visceral metastases 57 bladder carcinoma 57 Myalgia 57 Febrile neutropenia 57 alanine aminotransferase 57 8mg/kg 57 bronchial hyperresponsiveness 57 Resistant Hypertension 57 Prophylactic Treatment 57 Chemotherapy induced 57 p = #.# [003] 57 Inflammatory Markers 57 CIMZIA TM 57 Recurrences 57 bone marrow reticulin deposition 57 colorectal carcinoma 57 Non Responders 57 recurrent GBM 57 sero positive 57 indinavir 57 Invasive Breast Cancer 57 mucosal inflammation 57 bisoprolol 57 tigecycline 57 Protease Inhibitors 57 palmar plantar 57 postoperative nausea 57 nonfatal myocardial infarction MI 57 glycated hemoglobin 57 abacavir lamivudine 57 liver metastasis 57 benign nodules 57 Patients Undergoing 57 NHANES III 57 atrophic gastritis 57 cutaneous melanoma 57 canakinumab 57 Disease Progression 57 completely resected 57 LVNC 57 C difficile infection 57 mmol liter 57 elevated troponin 57 Treating Chronic 57 chronic HBV infection 57 mean baseline A1C 57 periprocedural 57 mutated KRAS 57 metastatic lung cancer 57 anemia hemoglobin 57 MMSE scores 57 eplerenone 57 metastatic carcinoid tumors 57 Infusion Reactions Severe 57 neurologic complications 57 intracranial hemorrhage ICH 57 response pCR 57 virologically 57 ST Segment Elevation 57 Stage IIB 57 Juvenile Idiopathic Arthritis 57 diarrhea nausea fatigue 57 rhinitis sinusitis 57 COPD exacerbation 57 antiandrogens 57 cytomegalovirus infection 57 NRTI sparing 57 infective endocarditis 57 allogeneic HSCT 57 % CI #.#-#.# [001] 57 cytogenetic response 57 annualized relapse 57 clomipramine 57 Recurrent Stroke 57 thrombocytosis 57 incontinence episodes 57 baseline HbA1c 57 P = .# 57 gm dl 57 stent thromboses 57 monoinfected patients 57 CI #.#-#.# [001] 57 FOLFOX4 alone 57 AGILECT R 57 anaplastic astrocytomas 57 efavirenz EFV 57 sensory neuropathy 57 T2DM 57 VT VF 57 IOP lowering 56 protease inhibitor PI 56 edifoligide 56 elevated IOP 56 K ras mutations 56 genital ulcers 56 Omiganan 56 benazepril 56 Treated Patients 56 coinfected patients 56 adalimumab Humira 56 nonfatal MI 56 HGPIN 56 Subtypes 56 acarbose 56 lupus anticoagulant 56 doxorubicin docetaxel 56 TMC# r 56 H. pylori eradication 56 hemorrhagic cystitis 56 INVEGA ® 56 Acute Renal Failure 56 adverse reactions occurring 56 noninferior 56 Nebulized 56 MADRS score 56 hemorrhagic complications 56 Exacerbation 56 HBeAg positive 56 Viread Emtriva Sustiva 56 events TEAEs 56 thyrotropin levels 56 leukemia ALL 56 follicular lymphomas 56 B Cell Lymphoma 56 Roche Herceptin 56 rash desquamation 56 Raynaud Disease 56 Enterobacter cloacae 56 refractory metastatic 56 de novo AML 56 Lowers Risk 56 colorectal carcinomas 56 symptomatic VTE 56 KRAS status 56 Rheumatoid Arthritis Patients 56 overt hypothyroidism 56 Drug Prevents 56 metastatic gastric 56 #Gy 56 fallopian tube carcinoma 56 preterm newborns 56 glycated hemoglobin HbA1c 56 Postherpetic Neuralgia 56 Acidosis 56 CDAI score 56 pegylated interferon alpha 56 Treatment Shows Promise 56 Hb A1C 56 NSTEMI 56 MRSA colonization 56 invasive ductal 56 virological failure 56 complement inhibitor eculizumab 56 NNRTI resistance 56 standard chemotherapy regimen 56 aphthous ulcers 56 Bacteremia 56 Abdominal Pain 56 nonadherent 56 neurodevelopmental impairment 56 hyperparathyroidism 56 haloperidol Haldol 56 preintervention 56 ALT normalization 56 efavirenz Sustiva 56 euthymic patients 56 ß blockers 56 intravenous bisphosphonates 56 Telithromycin 56 SGPT 56 ischemic lesions 56 Fasting plasma glucose 56 dermatologic reactions 56 antibiotic regimens 56 INCB# [003] 56 Allogeneic 56 decitabine 56 T#I [002] 56 decompensated liver disease 56 leukemia AML 56 pooled comparator 56 NNT = 56 initiating antiretroviral therapy 56 Cervical Dysplasia 56 mycophenolate mofetil 56 pancreatic adenocarcinoma 56 Ischemic Stroke 56 pharyngeal cancer 56 Myelosuppression 56 colorectal cancer CRC 56 mCRC patients 56 confidence intervals CIs 56 Chronic Pelvic Pain 56 Hazard Ratio 56 Fx adj 56 varicocele 56 FOLFIRI 56 lowest tertile 56 GISTs 56 mean baseline HbA1c 56 Major Adverse Cardiac 56 intracerebral haemorrhage 56 Prolongs Survival 56 fluoroquinolone resistance 56 μmol L 56 CR CRu 56 PRADAXA #mg 56 Treatment Naive Patients 56 postoperative morbidity 56 juvenile idiopathic arthritis JIA 56 albumin excretion rate 56 Iron Deficiency Anemia 56 response CCyR 56 BenzEFoam 56 CDAI 56 tirofiban 56 corticosteroid therapy 56 rFSH 56 â ‰ ¥ 56 chronic periodontitis 56 hepatitis B infection 56 severe periodontitis 56 hepatocellular cancer 56 ug dose 56 P ≤ 56 MRSA Infections 56 pegylated IFN 56 nonvertebral fractures 56 viral titers 56 resected pancreatic cancer 56 reflux esophagitis 56 Fungal Infections 56 postprocedure 56 HER2 amplification 56 CI -#.# 56 artery stenosis 56 Adhibit 56 Peg IFN 56 atazanavir ritonavir 56 uM 56 UPDRS motor 56 meropenem 56 #.#/#.# mmHg [001] 56 skeletal metastases 56 Atypical Hemolytic Uremic Syndrome 56 aspartate aminotransferase 56 systemic corticosteroid 56 systolic dysfunction 56 Mg Uk 56 ALT elevations 56 Free Survival PFS 56 Rheumatoid 56 ano genital warts 56 somnolence sedation 56 chronic GVHD 56 cranial irradiation 56 Kaplan Meier analysis 56 T1DM 56 LRTI 56 virologic failure 56 KRAS mutant tumors 56 confidence interval CI 56 Renal Impairment 56 abnormal Pap smear 56 genotypic resistance 56 laparoscopically assisted 56 G CSFs 56 myocardial fibrosis 56 cerebral vasospasm 56 radioiodine therapy 56 refractory AML 56 See WARNINGS 56 PHPT 56 gastric adenocarcinoma 56 Erythema 56 ribavirin therapy 56 Acute Myocardial Infarction 56 moderate renal impairment 56 hematologic abnormalities 56 seronegative 56 EXJADE 56 unfavorable cytogenetics 56 Unstable Angina 56 oral thrush 56 C. trachomatis 56 cystic fibrosis chronic pancreatitis 56 ADPKD 56 superficial bladder cancer 56 Helicobacter pylori eradication 56 boosted protease inhibitor 56 C. difficile diarrhea 56 Platinol ® 56 Aortic stenosis 56 virological response 56 precancers 56 del 5q MDS 56 R adefovir dipivoxil 56 CIN2 56 hours postdose 56 eosinophilic asthma 56 SLNB 56 parasitological 56 divalproex sodium 56 oral hypoglycemic 56 Hepatitis B Virus 56 pulmonary dysfunction 56 mmHg systolic 56 glulisine 56 quetiapine risperidone 56 peginterferon 56 timepoints 56 % CI #.#-#.# [006] 56 Ischaemic 56 Acute Coronary Syndromes 56 cytogenic 56 Premenopausal Women 56 NRTI resistance 56 multivariable adjusted 56 postoperative atrial fibrillation 56 -#.# ± [002] 56 Hydroxyurea 56 hemoglobin A1c HbA1c 56 mycophenolate mofetil MMF 56 mcg linaclotide 56 eosinophil count 56 MRSA bloodstream infection 56 microalbumin test 56 p = .# [002] 56 Angioedema 56 invasive lobular 56 myocardial reperfusion 56 Acute Physiology 56 oral olanzapine 56 recurrent UTI 56 Comorbidities 56 BCG vaccinated 56 acute GVHD 56 pimecrolimus cream 56 Vulvar 55 Endothelial Function 55 interstitial pneumonia 55 Known hypersensitivity 55 receiving VELCADE 55 urge urinary incontinence 55 PAOD 55 lipid lowering agents 55 DFMO 55 oral squamous cell 55 Breast Cancers 55 Cardiovascular Outcomes 55 HCV Genotype 55 basal cell carcinoma BCC 55 ocular toxicity 55 lamivudine monotherapy 55 nitroprusside 55 postoperative chemotherapy 55 bronchioloalveolar carcinoma 55 onset diabetes mellitus 55 adenoma recurrence 55 Valvular 55 B streptococcal 55 Boosts Survival 55 Univariate analysis 55 Is Well Tolerated 55 Advanced Prostate Cancer 55 HbA1C levels 55 paroxysmal atrial fibrillation 55 enterococcal 55 methotrexate monotherapy 55 griseofulvin 55 Liver Failure 55 severe oral mucositis 55 vWD 55 DAS# scores 55 Hemolysis 55 Legg Calvé Perthes disease 55 preoperative PSA 55 post transplant lymphoproliferative 55 Nosocomial 55 adverse reactions ≥ 55 symptomatic intracranial 55 Mg Usa 55 hemoglobin A1c levels 55 prednisone prednisolone plus 55 vertebral fracture 55 Postoperative 55 #mg doses [002] 55 Oesophageal 55 ejection fractions 55 severe rotavirus gastroenteritis 55 EDSS scores 55 Arrhythmias 55 recurrent tonsillitis 55 AVODART 55 PSADT 55 SPIRIVA ® 55 myalgia arthralgia 55 troponin T 55 Survival Benefit 55 Symptom Relief 55 thromboembolic disease 55 alemtuzumab treated 55 gross hematuria 55 stomatitis pharyngitis 55 TT genotype 55 transdermal estradiol 55 pharyngolaryngeal pain 55 neutropenia thrombocytopenia 55 Coronary Artery Bypass Graft 55 gonococcal 55 mRCC 55 intestinal metaplasia 55 nasopharyngitis 55 Lung Injury 55 mitoxantrone 55 inhospital mortality 55 GABHS 55 pretest probability 55 prostate cancer CaP 55 antiandrogen 55 mg p = 55 Ejection Fraction 55 anthracycline containing 55 HIV lipodystrophy 55 extracolonic findings 55 Acute myeloid leukemia 55 #mmHg [001] 55 FIRMAGON ® 55 Dengue Hemorrhagic Fever 55 Hyperlipidemia 55 variceal bleeding 55 tranylcypromine 55 mg BID dose 55 Index CDAI 55 ABC/3TC 55 Bloodstream infections 55 Diabetic Foot Ulcer 55 nitrofurantoin 55 hypercalciuria 55 serum urate 55 asymptomatic PAD 55 Elderly Patients 55 triglyceride concentrations 55 Multicenter Trial 55 cryptogenic 55 induce orthostatic hypotension 55 BENCHMRK 55 methicillin sensitive 55 HDRS 55 Respiratory Syncytial Virus RSV 55 thromboembolic 55 radical retropubic prostatectomy 55 Kepivance 55 Generalized Anxiety Disorder 55 Drug Resistant 55 achieved mucosal healing 55 platelet reactivity 55 Delayed Graft Function 55 vesicoureteral reflux 55 Microalbuminuria 55 estimated glomerular filtration 55 IELT 55 histologically confirmed 55 revascularization procedures 55 K#N 55 Benzoyl Peroxide 55 squamous cell carcinoma SCC 55 Pegasys peginterferon alfa 2a 55 MALT lymphoma 55 circulatory diseases 55 LPV r 55 beta blocker therapy 55 Diabetic Neuropathy 55 Staphylococcus aureus infections 55 Symptom Score 55 Gastritis 55 histological subtype 55 serologic testing 55 unresectable stage 55 non metastatic osteosarcoma 55 headache nausea diarrhea 55 STRIDE PD 55 transaminase elevation 55 Chlamydia trachomatis infection 55 lispro 55 preoperative chemotherapy 55 femoral neck fractures 55 Tumors shrank 55 graft occlusion 55 prospectively stratified 55 rectal tenesmus 55 Hydrochloride Injection 55 recurrent bladder 55 irinotecan chemotherapy 55 syphilis chlamydia 55 BladderChek 55 Complication rates 55 fluconazole resistant 55 Serious adverse reactions 55 progression TTP 55 asthenia fatigue 55 Hypertensive 55 asymptomatic carotid stenosis 55 Prostatectomy 55 null responder 55 ischemia driven 55 AADs 55 fluoroquinolone resistant 55 colorectal neoplasms 55 radical prostatectomy RP 55 arthralgias 55 Breast Cancer Recurrence 55 linaclotide treated 55 parasitemia 55 Rectal cancer 55 lopinavir r 55 Stent Thrombosis 55 renal toxicity 55 ARB telmisartan 55 sternal wound infections 55 ruptured aneurysms 55 abdominal irradiation 55 Combination therapy 55 NIH CPSI 55 gout flare 55 BRCA1 mutation carriers 55 μg L 55 neutropenic sepsis 55 postoperative AF 55 distant metastasis 55 Antihypertensive 55 stable angina